Linus Biotechnology Company
Linus Biotechnology develops a technology platform that builds on breakthroughs in exposome sequencing.
Headquarters:
New Rochelle, New York, United States
Total Funding:
17496637.0
Founded Date:
2020-01-01
Last Funding Type:
Series A
Investors Number:
7.0
Last Funding Date:
2023-01-05
Funding Status:
Early Stage Venture
Industry:
Early Drug Development